Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the ...

Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...

In Quebec, anti-obesity medications are on the list of exclusions of the Régie de l’assurance maladie du Québec (RAMQ). Quebec is the only Canadian province that does not evaluate obesity medications ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

NVIDIA CEO Jensen Huang and King Frederik X of Denmark launched Gefion, a supercomputer with 1,528 H100 AI GPUs designed to ...

Xeris is recognized for solid growth and innovative platforms. Learn more about XERS stock and why it's considered a Strong ...

Participants were survivors of acute ischemic strokes likely related to their Afib. In the hospital stroke unit, they were ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.

This week, Roche joined Eli Lilly in coming out against a deal that would add significant new manufacturing capacity to Novo ...

Market volatility in Q3 was driven by softer-than-expected US employment data, but resilient earnings and rate cuts led to a ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

The Dow, S&P 500, and Nasdaq were mixed Friday as the stock market digested the latest earnings and economic data.